Bob Roda
President and CEO, Menarini Silicon Biosystems
Bob Roda is a senior commercial executive with extensive experience in delivering business growth
and profit in the medtech and diagnostics sectors of healthcare. He currently serves as the President
and CEO of Menarini Silicon Biosystems, where he is responsible for driving the commercialization of
novel cancer diagnostics. Previously, Bob held a variety of roles of increasing commercial responsibility
at Becton Dickinson. Most recently, he was VP and General Manager of the MPS business unit as well as leading the
commercial integration of the CareFusion acquisition. Bob also had a successful career within the MD&D sector at Johnson
& Johnson. His diverse background includes positions in business development and senior leadership roles in sales and
marketing at Johnson & Johnson Medical, Inc., Ethicon, Inc. and Ortho-Clinical Diagnostics. While at J&J, Bob also served
as the executive sponsor of the Commercial Leadership Development Program as well as the chair of the VP Marketing
Council for all of MD&D. Bob is a highly respected, successful global leader with proven abilities in diverse disciplines. He
holds a Bachelor of Arts degree from The College of Business Administration at the University of Rhode Island.
Kristen Sharron-Albright
Head of Marketing, Noven Pharmaceuticals
Kristen Sharron-Albright, the current Head of Marketing at Noven Pharmaceuticals, was until recent-
ly VP Sales and Marketing, Anti-Infective Marketing and Institutional Sales Specialty Care Business
Unit at Pfizer. She is an experienced business leader with 20 years of experience in the pharmaceutical
and biotechnology industries. She has a strong track record of delivering results in highly competitive
and complex markets. Starting her career in sales at Eli Lilly, she then held positions of increasing responsibility at Lilly,
Neurogen, and Pfizer, where she was responsible for sales and marketing in a franchise business model. In her spare
time she volunteers, serves on the leadership committee for her church, and enjoys hiking.
Nick Gurreri
Vice President New Products, Alexion Pharmaceuticals, Inc.
Nick Gurreri is a business leader and General Manager with over 25 years of consistently achievinghigh
performance and profitability through strong leadership and cohesive team building in the biopharma-
ceutical and medical device industries. Nick has held executive positions at Medgenics, Insmed, Pfizer,
Pharmacia and Bristol-Myers Squibb. Nick received a BS in Mechanical Engineeringfrom the Univer-
sity of Delaware, and also acquired a Master of Science in Information Assurance at Carnegie Mellon University.
Lewis Chapman
Vice President, Global Commercial Operations, AllCells, LLC
Lewis Chapman is currently the Vice President, Global Operations at AllCells, LLC. He has spent
over thirty years in health care management. He served as VP of Global Strategic Marketing at
BioMarin Pharmaceutical from 2007 to 2012, where he was responsible for strategic marketing and
product portfolio analyses, and implemented medical education, brand enhancement and sales
support programs on a worldwide basis. He oversaw the global launch of Kuvan, which in the U.S. was 112% to budget
in 2008, the first year on the market. Previously, he worked with Alpha Inntech Corporation as Vice President Global
Sales and Marketing, where global sales grew 26% in 2004 and 22% in 2005 under his leadership. Lewis started his career
with Eli Lilly & Company, with roles at Syntex and Genentech, where he was responsible for the global commercial
launch of Activase (t-PA), the largest biopharm product launch in the history of the industry up to that time (first year
sales $187 million).
Editorial Board
